A preparation method of androsta-17β-n-(2,5-bis(trifluoromethyl))benzamide
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- HUNAN KEREY BIOTECH
- Publication Date
- 2017-02-08
Smart Images

Figure 1 
Figure 2
Abstract
Description
technical field
[0001] The invention relates to a preparation method of a pharmaceutical intermediate, in particular to a preparation method of androsta-17β-N-(2,5-bis(trifluoromethyl))benzamide. Background technique
[0002] Dutasteride is a drug for the treatment of benign prostatic hyperplasia and alopecia developed by Glaxo, with definite curative effect and few side effects. Its important intermediate androst-17β-N-(2,5-bis(trifluoromethyl))benzamide is amide formed from 2,5-bis(trifluoromethyl)aniline and androsta-17β-carboxylic acid Then, the general reaction formula is as follows:
[0003]
[0004] The current traditional production method is: use aromatic hydrocarbons or chlorinated hydrocarbons or DMF or pyridine as a solvent, a large amount of pyridine catalyzes and binds acids, and after forming acid chlorides, add a large excess of 2,5-bis(trifluoromethyl)aniline, high temperature Form amides, post-treatment is anhydrous concentration under reduced pressure...